BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Y, Pan Q, Xu H, Zhang R, Li J, Li F. Active uptake of 68Ga-FAPI in Crohn's disease but not in ulcerative colitis. Eur J Nucl Med Mol Imaging 2021;48:1682-3. [PMID: 33247327 DOI: 10.1007/s00259-020-05129-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Fu L, Zhou W. Active uptake of [18F]F-FAPI-42 in eosinophilic gastrointestinal disorder. Eur J Nucl Med Mol Imaging 2022. [DOI: 10.1007/s00259-022-06055-6] [Reference Citation Analysis]
2 Glatting FM, Hoppner J, Kauczor H, Huber PE, Kratochwil C, Giesel FL, Haberkorn U, Röhrich M. Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74. Cancers 2022;14:5301. [DOI: 10.3390/cancers14215301] [Reference Citation Analysis]
3 Lovinfosse P, Hustinx R. The role of PET imaging in inflammatory bowel diseases: state-of-the-art review. Q J Nucl Med Mol Imaging 2022;66. [DOI: 10.23736/s1824-4785.22.03467-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hotta M, Rieger AC, Jafarvand MG, Menon N, Farolfi A, Benz MR, Calais J. Non-oncologic incidental uptake on FAPI PET/CT imaging. Br J Radiol 2022;:20220463. [PMID: 35776566 DOI: 10.1259/bjr.20220463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li M, Younis MH, Zhang Y, Cai W, Lan X. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05706-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Rangarajan V, Choudhury S, Agrawal A, Puranik A, Shah S, Purandare N. Fibroblast activation protein inhibitors: New frontier of molecular imaging and therapy. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00113-7] [Reference Citation Analysis]
7 Dendl K, Koerber SA, Kratochwil C, Cardinale J, Finck R, Dabir M, Novruzov E, Watabe T, Kramer V, Choyke PL, Haberkorn U, Giesel FL. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? Cancers (Basel) 2021;13:4946. [PMID: 34638433 DOI: 10.3390/cancers13194946] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
8 Qin C, Song Y, Liu X, Gai Y, Liu Q, Ruan W, Liu F, Hu F, Lan X. Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond. Eur J Nucl Med Mol Imaging 2021. [PMID: 34241652 DOI: 10.1007/s00259-021-05472-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
9 Sollini M, Kirienko M, Gelardi F, Fiz F, Gozzi N, Chiti A. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2021. [PMID: 34173007 DOI: 10.1007/s00259-021-05475-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 26.0] [Reference Citation Analysis]
10 Rasheed J, Jamil A, Hameed AA, Al-Turjman F, Rasheed A. COVID-19 in the Age of Artificial Intelligence: A Comprehensive Review. Interdiscip Sci 2021;13:153-75. [PMID: 33886097 DOI: 10.1007/s12539-021-00431-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
11 Zhang Z, Tang R, Sun H, Dai H, Chen K, Ye X, Ye W, Li S, Lan B, Li L, Ou CQ. Temporal lung changes on thin-section CT in patients with COVID-19 pneumonia. Sci Rep 2020;10:19649. [PMID: 33184424 DOI: 10.1038/s41598-020-76776-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]